Likewise, no major phenotype, other than blindness, has been detected in patients carrying dominant or recessive mutations in the PROM1 gene [85], suggesting that CD133 is dispensable for general stem cell properties under physiological conditions [8, 86–88]. The gene discussed is PROM1; the disease is blindness (disorder).